BioCentury
ARTICLE | Company News

Biscayne Pharmaceuticals, Insero Health deal

November 2, 2015 8:00 AM UTC

Biscayne merged with Insero on June 30. Biscayne is developing growth hormone-releasing hormone (GHRH) receptor analogs. Biscayne’s lead compound is BIS-001, a selective acetylcholinesterace (AChE) i...